Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.

American journal of obstetrics and gynecology - 1 Apr 2014

Manuck Tracy A, Watkins W Scott, Moore Barry, Esplin M Sean, Varner Michael W, Jackson G Marc, Yandell Mark, Jorde Lynn

Abstract excerpt

OBJECTIVE: We hypothesized that genetic variation affects responsiveness to 17-alpha hydroxyprogesterone caproate (17P) for recurrent preterm birth prevention. STUDY DESIGN: Women of European ancestry with ≥1 spontaneous singleton preterm birth at <34 weeks' gestation who received 17P were recruited prospectively and classified as a 17P responder or nonresponder by the difference in delivery gestational age...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Estrogen Antagonists
Share to Exome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nitric Oxide Synthase

Share to Nitric Oxide Synthase Type I

Share to Pharmacogenetics

Share to Pregnancy

Share to Premature Birth

Share to Secondary Prevention

Source

Open in PubMed Open full text

Identifiers

PMID: 24594138
DOI: 10.1016/j.ajog.2014.01.013
PMCID: PMC4266558

Genes

NOS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.PMID 24594138Read ↗

Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate.Semantic proximity Read ↗

The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.Semantic proximity Read ↗

Integrative analysis of noncoding mutations identifies the druggable genome in preterm birth.Semantic proximity Read ↗

Genetics, hormonal influences, and preterm birth.Semantic proximity Read ↗

Identification of potential therapeutic intervening targets by in-silico analysis of nsSNPs in preterm birth-related genes.Semantic proximity Read ↗

Kir7.1 is the physiological target for hormones and steroids that regulate uteroplacental functionSemantic proximity Read ↗

Identifying genetic variants associated with ritodrine-induced pulmonary edema.Semantic proximity Read ↗

Genetic Variants of Progesterone Receptor in Etiology of Preterm DeliverySemantic proximity Read ↗

Association Between Genetic Polymorphisms in the Prostaglandin Pathway and the Development of Patent Ductus Arteriosus in Preterm InfantsSemantic proximity Read ↗

Prostanoid DP receptor (PTGDR) variants in mothers with post-coital associated preterm births: preliminary observations.Semantic proximity Read ↗

Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.Semantic proximity Read ↗

Glucocorticoid Receptor Regulated KCNA5 Mediates Cell Proliferation in Human Fetal MembranesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.